IN THE MATTER OF the Patent Act R.S.C. 1985, c. P-4,
AND IN THE MATTER OF Abbott Laboratories Limited
(the “Respondent”) and the medicine “Zemplar”
Pursuant to subsection 83(6) of the Patent Act, the Patented Medicine Prices Review Board (the “Board”) issued a Notice of Hearing on July 24, 2007, pertaining to the medicine Zemplar IV.
On September 17, 2007, the Respondent filed a Voluntary Compliance Undertaking (the “VCU”) by which the Respondent proposed to resolve all issues raised by the Notice of Hearing. A copy of the VCU is attached.
The Board has decided to accept the Respondent's VCU. Accordingly, the Board hereby orders the Respondent to comply with the VCU and concludes the proceeding that was commenced by the issuance of the Notice of Hearing.
Board Members: Brien G. Benoit, MD
Board Counsel: Gordon Cameron
Secretary of the Board
Date: September 19, 2007